Susan M. Stalnecker

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: Leidos Holdings Inc., 3 years.

3 years ยท Since 2023
Bioventus Inc. Director
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Feb 18, 2025 Leidos Holdings Inc. Option exercise +4,070 $63.08 $256,736
Feb 18, 2025 Leidos Holdings Inc. Option exercise +3,345 $75.02 $250,942
Feb 18, 2025 Leidos Holdings Inc. Option exercise +2,123 $103.90 $220,580
Feb 18, 2025 Leidos Holdings Inc. Option exercise +1,769 $104.06 $184,082
Feb 18, 2025 Leidos Holdings Inc. Option exercise +2,296 $79.45 $182,417
Feb 18, 2025 Leidos Holdings Inc. Shares withheld for tax โˆ’8,278 $132.26 $1,094,848
Jun 7, 2024 Bioventus Inc. Option exercise +30,400 โ€” โ€”
May 3, 2024 Leidos Holdings Inc. Grant or award +912 โ€” โ€”
May 2, 2024 Leidos Holdings Inc. Option exercise +4,788 $52.70 $252,328
May 2, 2024 Leidos Holdings Inc. Shares withheld for tax โˆ’1,774 $142.19 $252,245
May 2, 2024 Leidos Holdings Inc. Open-market sale โˆ’3,014 $141.97 $427,898
Jun 6, 2023 Bioventus Inc. Option exercise +16,648 โ€” โ€”
May 12, 2023 Leidos Holdings Inc. Option exercise +5,193 $39.70 $206,162
May 12, 2023 Leidos Holdings Inc. Shares withheld for tax โˆ’2,634 $78.27 $206,163
May 5, 2023 Leidos Holdings Inc. Grant or award +1,574 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.